Photo from dana-farber.org
Sep 20, 2023, 18:14
A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.
Quoting Dana-Farber News on X/Twitter:
“Eli Van Allen, Jackson Nyman (Dana-Farber Cancer Institute) and Toni Choueiri (Dana-Farber Lank Center for Genitourinary Oncology) identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC), a form of kidney cancer, using image processing with deep learning.”
For details click here.
Source: Dana-Farber News/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 03:12
Sep 4, 2025, 03:01
Sep 4, 2025, 00:02
Sep 3, 2025, 22:35
Sep 3, 2025, 22:09
Sep 3, 2025, 20:48